TY - JOUR
T1 - Idiopathic pulmonary fibrosis and gastroesophageal reflux disease
T2 - A population-based, case-control study
AU - Baqir, Misbah
AU - Vasirreddy, Amit
AU - Vu, Ann N.
AU - Moua, Teng
AU - Chamberlain, Alanna M.
AU - Frank, Ryan D.
AU - Ryu, Jay H.
N1 - Funding Information:
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agency had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Publisher Copyright:
© 2021
PY - 2021/3
Y1 - 2021/3
N2 - Background: It is unknown whether gastroesophageal reflux disease (GERD) is a risk factor or consequence of idiopathic pulmonary fibrosis (IPF). This study aimed to determine whether patients with IPF were more likely to have GERD compared with age- and sex-matched controls who either had 1) interstitial lung disease (ILD) other than IPF or 2) no diagnosed lung disease (population control). Methods: We used the medical records-linkage system of the Rochester Epidemiology Project (REP) to identify patients with IPF who resided in Olmsted County, Minnesota, from January 1, 1997, through June 30, 2017. IPF cases were each matched with patients from 2 control groups (non-IPF ILD controls and population controls). We used conditional logistic regression to model associations between GERD diagnosis and IPF case status. P values were adjusted for multiple comparisons by using the Bonferroni adjustment (P values <.025 were considered statistically significant). Results: One hundred thirteen IPF cases were identified and matched to 226 population controls and 226 controls with non-IPF ILD. After multivariable adjustment, the odds of having GERD were 1.78 times higher (95% CI, 1.09–2.91; P =.02) in IPF cases compared with population controls. After multivariable adjustment, the odds of having GERD were 0.46 times lower (95% CI, 0.23–0.94; P =.03) in IPF cases compared with non-IPF ILD controls. Conclusion: GERD may be an important contributor to the development of lung fibrosis. Thus, it should be investigated and addressed adequately when detected in patients with IPF and patients with non-IPF ILD.
AB - Background: It is unknown whether gastroesophageal reflux disease (GERD) is a risk factor or consequence of idiopathic pulmonary fibrosis (IPF). This study aimed to determine whether patients with IPF were more likely to have GERD compared with age- and sex-matched controls who either had 1) interstitial lung disease (ILD) other than IPF or 2) no diagnosed lung disease (population control). Methods: We used the medical records-linkage system of the Rochester Epidemiology Project (REP) to identify patients with IPF who resided in Olmsted County, Minnesota, from January 1, 1997, through June 30, 2017. IPF cases were each matched with patients from 2 control groups (non-IPF ILD controls and population controls). We used conditional logistic regression to model associations between GERD diagnosis and IPF case status. P values were adjusted for multiple comparisons by using the Bonferroni adjustment (P values <.025 were considered statistically significant). Results: One hundred thirteen IPF cases were identified and matched to 226 population controls and 226 controls with non-IPF ILD. After multivariable adjustment, the odds of having GERD were 1.78 times higher (95% CI, 1.09–2.91; P =.02) in IPF cases compared with population controls. After multivariable adjustment, the odds of having GERD were 0.46 times lower (95% CI, 0.23–0.94; P =.03) in IPF cases compared with non-IPF ILD controls. Conclusion: GERD may be an important contributor to the development of lung fibrosis. Thus, it should be investigated and addressed adequately when detected in patients with IPF and patients with non-IPF ILD.
KW - Gastroesophageal reflux
KW - Idiopathic pulmonary fibrosis
KW - Interstitial lung disease
UR - http://www.scopus.com/inward/record.url?scp=85100057876&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100057876&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2021.106309
DO - 10.1016/j.rmed.2021.106309
M3 - Article
C2 - 33517156
AN - SCOPUS:85100057876
SN - 0954-6111
VL - 178
JO - Respiratory Medicine
JF - Respiratory Medicine
M1 - 106309
ER -